Personalizing Anticoagulant Treatment: Risk Stratification and Your Patient
Target Audience:
This activity has been developed for cardiologists and health care providers who manage patients with, or are at risk for, AF or thrombotic events.
Program Overview
This enhanced Webcast conference capture contains footage from a live satellite symposium conducted on November 18, 2013, in Dallas, Texas, which features up-to-the-minute clinical data from the 2013 AHA Scientific Sessions, along with postsymposium faculty commentary on emerging therapies. The educational activity addresses key issues and controversies associated with AF and thrombotic events, making it relevant for clinicians from multiple disciplines in terms of risk reduction and improved patient outcomes.
The program's discussion-based format offers different perspectives from expert faculty on how to best tailor anticoagulant therapy to the individual patient. Best practices for treatment initiation and long-term management with currently approved anticoagulants, as well as implications for investigative agents are discussed.
Estimated time to complete: 90 minutes.
Sponsor:
This CME activity is jointly sponsored by Penn State College of Medicine and CME Incite.
Grantor:
This activity is funded through an unrestricted educational grant from Daiichi Sankyo.
Accreditation:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Penn State College of Medicine and CME Incite. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
For questions regarding CME credit for this activity, please call Penn State Continuing Education at (717) 531-6483 or e-mail ContinuingEd@hmc.psu.edu. Refer to course # G5388-14-T.
Credit Designation:
Penn State College of Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Faculty Listing:
Robert P. Giugliano, MD, SM (Chairperson)
Senior Investigator, TIMI Study Group
Physician, Cardiovascular Medicine
Brigham and Women's Hospital
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts
Elaine M. Hylek, MD, MPH
Professor of Medicine
Department of Medicine
Boston University School of Medicine
Director, Thrombosis Clinic and Anticoagulation Service
Boston, Massachusetts
Christian T. Ruff, MD, MPH
Associate Physician
Cardiovascular Division
Brigham and Women's Hospital
Instructor in Medicine
Harvard Medical School
Boston, Massachusetts
Objectives:
- Identify patients with nonvalvular atrial fibrillation (AF) and venous thromboembolism (VTE) who would benefit from anticoagulant treatment in order to decrease the occurrence of adverse thrombotic events
- Recommend anticoagulant therapy by matching an individual patient's profile with the appropriate agents for maximum risk reduction and safety
- Determine the risk-to-benefit ratio of anticoagulant therapy in aging patients to improve their overall health and quality of life
Financial Disclosure:
It is Penn State's policy to ensure balance, independence, objectivity, and scientific rigor in all of our educational programs. Faculty and course directors have disclosed relevant financial relationships with commercial companies, and Penn State has a process in place to resolve any conflict of interest. Complete faculty disclosure will be provided to program participants at the beginning of the activity.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Name of Faculty or Presenter | Reported Financial Relationship |
Robert P. Giugliano, MD, SM | Consultant: Daiichi Sankyo, Janssen, Merck, Sanofi-aventis Research Grant: Co-Principal Investigator: ENGAGE AF-TIMI 48 |
Elaine M. Hylek, MD, MPH | Consultant/Advisor: Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Janssen |
Christian T. Ruff, MD, MPH | Consultant/Advisor: Boehringer Ingelheim, Daiichi Sankyo |
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Name of Planner or Manager | Reported Financial Relationship |
Rose O'Connor, PhD (CME Incite) Penn State College of Medicine faculty and staff | No financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months. |
John Boehmer, MD (reviewer from Penn State College of Medicine) | Consultant: Boston Scientific, Medtronic, St Jude Medical; Research Grant: St Jude Medical |